Literature DB >> 29058285

Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells.

Rui Cheng1, Xin-Ran Cai1, Kun Ke2, Yan-Ling Chen3.   

Abstract

Vasculogenic mimicry (VM) is a process by which aggressive tumor cells generate non-endothelial cell-lined channels in malignant tumors including hepatocellular carcinoma (HCC). It has provided new insights into tumor behavior and has surfaced as a potential target for drug therapy. The molecular events underlying the process of VM formation are still poorly understood. In this study, we attempted to elucidate the relationship between Notch4 and VM formation in HCC. An effective siRNA lentiviral vector targeting Notch4 was constructed and transfected into Bel7402, a HCC cell line. VM networks were observed with a microscope in a 3 dimensional cell culture system. Cell migration and invasion were evaluated using wound healing and transwell assays. Matrix metalloproteinases (MMPs) activity was detected by gelatin zymography. Furthermore, the role of Notch4 inhibition in Bel7402 cells in vivo was examined in subcutaneous xenograft tumor model of mice. The results showed that downregulation of Notch4 destroyed VM network formation and inhibited migration and invasion of tumor cells in vitro (P<0.05). In vivo, tumor growth was also inhibited in subcutaneous xenograft model (P<0.05). The potential mechanisms might be related with down-regulation of MT1-MMP, MMP-2, MMP-9 expression and inhibition of the activation of MMP2 and MMP9. These results indicated that Notch4 may play an important role in VM formation and tumor invasion in HCC. Related molecular pathways may be used as novel therapeutic targets for HCC antiangiogenesis therapy.

Entities:  

Keywords:  Notch4; hepatocellular carcinoma; invasion; matrix metalloproteinase; vasculogenic mimicry

Mesh:

Substances:

Year:  2017        PMID: 29058285     DOI: 10.1007/s11596-017-1794-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  35 in total

Review 1.  Antiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agents.

Authors:  Gabriel Limaverde-Sousa; Cinthya Sternberg; Carlos Gil Ferreira
Journal:  Cancer Treat Rev       Date:  2013-12-06       Impact factor: 12.111

Review 2.  Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.

Authors:  Agata Jabłońska-Trypuć; Marzena Matejczyk; Stanisław Rosochacki
Journal:  J Enzyme Inhib Med Chem       Date:  2016-03-30       Impact factor: 5.051

Review 3.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

4.  Paris polyphylla Suppresses Proliferation and Vasculogenic Mimicry of Human Osteosarcoma Cells and Inhibits Tumor Growth In Vivo.

Authors:  Nan Yao; Ke Ren; Yimin Wang; Qiaomei Jin; Xiao Lu; Yan Lu; Cuihua Jiang; Dongjian Zhang; Jun Lu; Chen Wang; Jiege Huo; Yong Chen; Jian Zhang
Journal:  Am J Chin Med       Date:  2017-04-06       Impact factor: 4.667

5.  Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium.

Authors:  H Uyttendaele; J Ho; J Rossant; J Kitajewski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

6.  miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.

Authors:  Xuemin Liu; Anpeng Zhang; Junxi Xiang; Yi Lv; Xufeng Zhang
Journal:  Oncol Rep       Date:  2016-07-25       Impact factor: 3.906

7.  BLOS2 negatively regulates Notch signaling during neural and hematopoietic stem and progenitor cell development.

Authors:  Wenwen Zhou; Qiuping He; Chunxia Zhang; Xin He; Zongbin Cui; Feng Liu; Wei Li
Journal:  Elife       Date:  2016-10-10       Impact factor: 8.140

8.  The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition.

Authors:  Zi Cao; Baocun Sun; Xiulan Zhao; Yanhui Zhang; Qiang Gu; Xiaohui Liang; Xueyi Dong; Nan Zhao
Journal:  Int J Mol Sci       Date:  2017-02-27       Impact factor: 5.923

9.  Slug promoted vasculogenic mimicry in hepatocellular carcinoma.

Authors:  Dan Sun; Baocun Sun; Tieju Liu; Xiulan Zhao; Na Che; Qiang Gu; Xueyi Dong; Zhi Yao; Rui Li; Jing Li; Jiadong Chi; Ran Sun
Journal:  J Cell Mol Med       Date:  2013-07-01       Impact factor: 5.310

10.  Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells.

Authors:  Mathangi Ravi; Shilpa Tentu; Ganga Baskar; Surabhi Rohan Prasad; Swetha Raghavan; Prajisha Jayaprakash; Jeyaraman Jeyakanthan; Suresh K Rayala; Ganesh Venkatraman
Journal:  BMC Cancer       Date:  2015-10-23       Impact factor: 4.430

View more
  6 in total

1.  Targeted sequencing of NOTCH signaling pathway genes and association analysis of variants correlated with mandibular prognathism.

Authors:  Xianzhuo Han; Xueyan Xiong; Xiujuan Shi; Fengshan Chen; Yongming Li
Journal:  Head Face Med       Date:  2021-05-26       Impact factor: 2.151

2.  [Mig-7 gene silencing inhibits vasculogenic mimicry formation and invasion of glioma U251 cells in vitro by suppressing MEK/ERK signaling].

Authors:  Fan Wang; Fenglong Chen; Weipeng Hu; Yi Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-05-30

3.  CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway.

Authors:  Rui Cheng; Bi Wang; Xin-Ran Cai; Zhi-Shan Chen; Qiang Du; Liang-Yi Zhou; Jing-Min Ye; Yan-Ling Chen
Journal:  Onco Targets Ther       Date:  2020-11-10       Impact factor: 4.147

Review 4.  Vasculogenic mimicry in carcinogenesis and clinical applications.

Authors:  Qingxi Luo; Jun Wang; Wenyuan Zhao; Zhenzi Peng; Xianyu Liu; Bin Li; Heng Zhang; Bin Shan; Chunfang Zhang; Chaojun Duan
Journal:  J Hematol Oncol       Date:  2020-03-14       Impact factor: 17.388

5.  Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.

Authors:  Yichao Wang; Ruixue Yang; Xiaolin Wang; Hongfei Ci; Lei Zhou; Bo Zhu; Shiwu Wu; Danna Wang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

6.  Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.

Authors:  Shixiang Bao; Shuai Jin; Chunhua Wang; Peipei Tu; Kongwang Hu; Jingtao Lu
Journal:  J Cell Mol Med       Date:  2020-10-28       Impact factor: 5.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.